US646572A
(en)
*
|
1899-03-15 |
1900-04-03 |
Archibald C Floyd |
Bath-cabinet.
|
CH624395A5
(es)
*
|
1976-01-08 |
1981-07-31 |
Ciba Geigy Ag |
|
US4343940A
(en)
|
1979-02-13 |
1982-08-10 |
Mead Johnson & Company |
Anti-tumor quinazoline compounds
|
EP0054132B1
(de)
*
|
1980-12-12 |
1984-10-10 |
Dr. Karl Thomae GmbH |
Neue Pyrimidinone, ihre Herstellung und Arzneimittel mit einem Gehalt an diesen Stoffen
|
US4431440A
(en)
*
|
1981-02-20 |
1984-02-14 |
American Cyanamid Company |
Method to alter or control the development and/or the life cycle of various plant species
|
US4422711A
(en)
|
1981-12-21 |
1983-12-27 |
Amp Incorporated |
Active pin contact
|
US4588812A
(en)
*
|
1984-05-30 |
1986-05-13 |
Pennwalt Corporation |
Substituted 2,3-dihydro-5H-thiazolo[2,3,-b]quinazoline derivatives
|
GB8429739D0
(en)
*
|
1984-11-24 |
1985-01-03 |
Fbc Ltd |
Fungicides
|
GB8513754D0
(en)
|
1985-05-31 |
1985-07-03 |
Jones T R |
Anti-cancer quinazoline derivatives
|
GB8811435D0
(en)
*
|
1988-05-13 |
1988-06-15 |
Ici Plc |
Fungicides
|
DE68928783T2
(de)
|
1988-11-21 |
1998-12-24 |
Zeneca Ltd |
Zwischenverbindungen zur Herstellung von Fungiziden
|
GB8827988D0
(en)
|
1988-11-30 |
1989-01-05 |
Smith Kline French Lab |
Chemical compounds
|
IE62559B1
(en)
*
|
1989-02-02 |
1995-02-08 |
Ici Plc |
Fungicides
|
US5145856A
(en)
|
1989-02-10 |
1992-09-08 |
Imperial Chemical Industries Plc |
Fungicides
|
BE1003002A6
(fr)
|
1989-03-21 |
1991-10-22 |
Coppe Jan |
Composition a mettre en oeuvre pour le traitement de la calvitie, et procedes faisant usage de celle-ci.
|
GB8914797D0
(en)
*
|
1989-06-28 |
1989-08-16 |
Ici Plc |
Fungicides
|
US5240928A
(en)
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
US5187779A
(en)
*
|
1989-08-11 |
1993-02-16 |
Micral, Inc. |
Memory controller with synchronous processor bus and asynchronous i/o bus interfaces
|
GB9016783D0
(en)
|
1989-09-01 |
1990-09-12 |
Ici Plc |
Agrochemical compositions
|
GB8928547D0
(en)
*
|
1989-12-18 |
1990-02-21 |
Ici Plc |
Fungicides
|
AU6812790A
(en)
|
1989-12-22 |
1991-06-27 |
Ici Americas Inc. |
Fungicidal compounds
|
GB9000130D0
(en)
*
|
1990-01-04 |
1990-03-07 |
Ici Plc |
Fungicides
|
US5264439A
(en)
|
1990-02-13 |
1993-11-23 |
Merck & Co., Inc. |
Quinazolinone, triazolinone and pyrimidinone angiotensin II antagonists incorporating a substituted benzyl element
|
CA2037630C
(en)
*
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
GB9012017D0
(en)
*
|
1990-05-30 |
1990-07-18 |
Ici Plc |
Fungicidal compounds
|
GB9013615D0
(en)
|
1990-06-19 |
1990-08-08 |
Wellcome Found |
Pharmaceutical compounds
|
US5225318A
(en)
*
|
1990-07-02 |
1993-07-06 |
Ocg Microelectronic Materials, Inc. |
Selected photoactive methylolated cyclohexanol compounds and their use in forming positive resist image patterns
|
IE74711B1
(en)
*
|
1990-07-27 |
1997-07-30 |
Ici Plc |
Fungicides
|
GB9016578D0
(en)
|
1990-07-27 |
1990-09-12 |
Ici Plc |
Fungicides
|
GB9016584D0
(en)
*
|
1990-07-27 |
1990-09-12 |
Ici Plc |
Fungicides
|
GB9018408D0
(en)
|
1990-08-22 |
1990-10-03 |
Ici Plc |
Fungicides
|
US5110471A
(en)
*
|
1990-08-30 |
1992-05-05 |
Conoco Specialty Products Inc. |
High efficiency liquid/liquid hydrocyclone
|
GB9023294D0
(en)
|
1990-10-25 |
1990-12-05 |
Ici Plc |
Fungicides
|
US5290780A
(en)
*
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5385894A
(en)
*
|
1991-03-06 |
1995-01-31 |
Merck & Co., Inc. |
Disubstituted 6-aminoquinazolinones
|
NZ242290A
(en)
|
1991-04-15 |
1994-12-22 |
Zeneca Ltd |
Pyridyl and pyrimidinyl substituted oxime-o-benzyl ether derivatives; preparatory processes, fungicidal compositions and an intermediate
|
US5252574A
(en)
|
1991-04-26 |
1993-10-12 |
Merck & Co., Inc. |
Angiotensin II antagonists incorporating a substituted thiophene or furan
|
US5162325A
(en)
|
1991-05-07 |
1992-11-10 |
Merck & Co., Inc. |
Angiotensin ii antagonists incorporating a substituted benzyl element
|
AU658646B2
(en)
*
|
1991-05-10 |
1995-04-27 |
Rhone-Poulenc Rorer International (Holdings) Inc. |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
|
US5158953A
(en)
|
1991-08-13 |
1992-10-27 |
National Science Council |
2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof
|
US6011068A
(en)
*
|
1991-08-23 |
2000-01-04 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
US6313146B1
(en)
|
1991-08-23 |
2001-11-06 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
US6031003A
(en)
*
|
1991-08-23 |
2000-02-29 |
Nps Pharmaceuticals, Inc. |
Calcium receptor-active molecules
|
DE4130298A1
(de)
|
1991-09-12 |
1993-03-18 |
Basf Ag |
Fungizide mischungen
|
GB9126260D0
(en)
*
|
1991-12-11 |
1992-02-12 |
Pfizer Ltd |
Therapeutic agents
|
DE4243340A1
(de)
*
|
1992-12-21 |
1994-06-23 |
Sued Chemie Ag |
Sorptionsmittel
|
US5420133A
(en)
*
|
1993-03-19 |
1995-05-30 |
Merck & Co., Inc. |
Quinazolinones substituted with phenoxyphenylacetic acid derivatives
|
US5401745A
(en)
*
|
1993-03-19 |
1995-03-28 |
Merck & Co., Inc. |
Quinazolinones substituted with phenoxyphenylacetic acid derivatives
|
DE59400216D1
(de)
|
1993-09-24 |
1996-05-23 |
Basf Ag |
Fungizide Mischungen
|
US5721236A
(en)
*
|
1993-10-15 |
1998-02-24 |
Schering Corporation |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
|
JP3364727B2
(ja)
*
|
1993-10-22 |
2003-01-08 |
イハラケミカル工業株式会社 |
2,2−ビス(3,5−ジ置換−4−ヒドロキシフェニル)プロパン誘導体とその製造方法およびこの誘導体を用いるピロガロールの製造法
|
US5464854A
(en)
*
|
1993-11-11 |
1995-11-07 |
Depadova; Anathony S. |
Method of modifying ovarian hormone-regulated AT1 receptor activity as treatment of incapacitating symptom(s) of P.M.S.
|
US5756502A
(en)
*
|
1994-08-08 |
1998-05-26 |
Warner-Lambert Company |
Quinazolinone derivatives as cholyecystokinin (CCK) ligands
|
CN1312116C
(zh)
*
|
1994-10-21 |
2007-04-25 |
Nps药物有限公司 |
钙受体活性化合物
|
GB2295387A
(en)
|
1994-11-23 |
1996-05-29 |
Glaxo Inc |
Quinazoline antagonists of alpha 1c adrenergic receptors
|
GB9423911D0
(en)
|
1994-11-26 |
1995-01-11 |
Pfizer Ltd |
Therapeutic agents
|
DE19501481A1
(de)
*
|
1995-01-19 |
1996-07-25 |
Bayer Ag |
2,8-Disubstituierte Chinazolinone
|
ES2332984T3
(es)
|
1995-03-30 |
2010-02-16 |
Pfizer Products Inc. |
Derivados de quinazolinas.
|
MY115814A
(en)
|
1995-06-16 |
2003-09-30 |
Bayer Ip Gmbh |
Crop protection compositions
|
US5994382A
(en)
|
1995-08-17 |
1999-11-30 |
Basf Aktiengesellschaft |
Fungicidal mixtures
|
US6897213B1
(en)
|
1995-11-21 |
2005-05-24 |
Warner-Lambert Company |
Heterocycles as cholecystokinin (CCK) ligands
|
JPH09241110A
(ja)
*
|
1996-03-08 |
1997-09-16 |
Sumitomo Chem Co Ltd |
殺菌剤組成物
|
DE59706870D1
(de)
*
|
1996-04-26 |
2002-05-08 |
Basf Ag |
Fungizide mischung
|
EP0900021B1
(de)
*
|
1996-04-26 |
2002-06-19 |
Basf Aktiengesellschaft |
Fungizide mischung
|
PL330042A1
(en)
|
1996-05-15 |
1999-04-26 |
Pfizer |
Novel 2,3-disubstituted 4(3h)-quinazolynones
|
PT912559E
(pt)
*
|
1996-07-13 |
2003-03-31 |
Glaxo Group Ltd |
Compostos heterociclicos fundidos como inibidores de proteina tirosina quinase
|
DE19629825A1
(de)
|
1996-07-24 |
1998-01-29 |
Bayer Ag |
Dihydrofuran-carboxamide
|
CA2265495A1
(en)
|
1996-09-13 |
1998-03-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Non-hormonal method of contraception
|
US6225318B1
(en)
*
|
1996-10-17 |
2001-05-01 |
Pfizer Inc |
4-aminoquinazolone derivatives
|
US6331543B1
(en)
|
1996-11-01 |
2001-12-18 |
Nitromed, Inc. |
Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
|
SK113199A3
(en)
*
|
1997-02-28 |
2001-10-08 |
Pfizer Prod Inc |
Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
|
ID22711A
(id)
|
1997-02-28 |
1999-12-09 |
Pfizer Prod Inc |
Atropisomer dari 3-aril-4(3h)-kinazolinon dan penggunaannya sebagai antagonis reseptor-ampa
|
US5948775A
(en)
*
|
1997-03-19 |
1999-09-07 |
American Home Products Corporation |
2- or 3-(substitutedaminoalkoxyphenyl)quinazolin-4-ones
|
FR2762841B1
(fr)
*
|
1997-04-30 |
1999-07-02 |
Jouveinal Inst Rech |
Diazepino-indolones inhibitrices de phosphodiesterases iv
|
CO5050364A1
(es)
|
1997-05-28 |
2001-06-27 |
Basf Ag |
Metodo para controlar hongos nocivos
|
SI0986304T1
(en)
*
|
1997-06-04 |
2002-10-31 |
Basf Aktiengesellschaft |
Fungicidal mixture
|
US6627755B1
(en)
|
1997-06-09 |
2003-09-30 |
Pfizer Inc |
Quinazolin-4-one AMPA antagonists
|
US6060479A
(en)
*
|
1997-06-09 |
2000-05-09 |
Pfizer Inc |
Quinazoline-4-one AMPA antagonists
|
US5753851A
(en)
*
|
1997-06-16 |
1998-05-19 |
The United States Of America As Represented By The Secretary Of The Army |
Spinning mine with concentrated projectiles
|
EP0900567A3
(en)
|
1997-09-05 |
2001-05-02 |
Pfizer Products Inc. |
Quinazoline-4-one AMPA antagonists for the treatment of dyskinesias associated with dopamine agonist therapy
|
IL125950A0
(en)
|
1997-09-05 |
1999-04-11 |
Pfizer Prod Inc |
Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
|
US20030069231A1
(en)
|
1999-10-12 |
2003-04-10 |
Klaus Rudolf |
Modified aminoacids, pharmaceuticals containing these compounds and method for their production
|
JP2959765B2
(ja)
*
|
1997-12-12 |
1999-10-06 |
日本たばこ産業株式会社 |
3−ピペリジル−4−オキソキナゾリン誘導体及びそれを含有してなる医薬組成物
|
TW431861B
(en)
*
|
1997-12-18 |
2001-05-01 |
Basf Ag |
Fungicidal mixtures based on amide compounds and azoles
|
GB9800569D0
(en)
*
|
1998-01-12 |
1998-03-11 |
Glaxo Group Ltd |
Heterocyclic compounds
|
KR20010034442A
(ko)
*
|
1998-01-27 |
2001-04-25 |
아벤티스 파마슈티칼즈 프로덕츠 인코포레이티드 |
치환된 옥소아자헤테로사이클릴 인자 Xa 억제제
|
JPH11279158A
(ja)
|
1998-02-09 |
1999-10-12 |
Pfizer Prod Inc |
キナゾリン―4―オン誘導体の製造方法
|
JPH11228643A
(ja)
*
|
1998-02-17 |
1999-08-24 |
Menicon Co Ltd |
眼用レンズ材料およびその製法
|
JP2002505288A
(ja)
|
1998-03-02 |
2002-02-19 |
コセンシス,インコーポレイテッド |
置換キナゾリンおよびアナログならびにそれらの使用
|
US6337332B1
(en)
*
|
1998-09-17 |
2002-01-08 |
Pfizer Inc. |
Neuropeptide Y receptor antagonists
|
US6187779B1
(en)
*
|
1998-11-20 |
2001-02-13 |
Cell Pathways, Inc. |
Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives
|
US6225315B1
(en)
*
|
1998-11-30 |
2001-05-01 |
Pfizer Inc |
Method of treating nitrate-induced tolerance
|
GB9828340D0
(en)
|
1998-12-22 |
1999-02-17 |
Novartis Ag |
Organic compounds
|
US6270781B1
(en)
*
|
1999-01-08 |
2001-08-07 |
Maxim Pharmaceuticals, Inc. |
Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
|
DE19911509A1
(de)
|
1999-03-15 |
2000-09-21 |
Boehringer Ingelheim Pharma |
Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
|
FR2792938B1
(fr)
|
1999-04-28 |
2001-07-06 |
Warner Lambert Co |
NOUVELLES 1-AMINO TRIAZOLO [4,3-a] QUINAZOLINE-5-ONES INHIBITRICES DE PHOSPHODIESTERASES IV
|
DE60031285T2
(de)
*
|
1999-08-27 |
2007-08-30 |
Chemocentryx Inc., Mountain View |
Heterozyclische verbindungen und verfahren zur modulierung von cxcr3 funktion
|
US7060706B1
(en)
*
|
1999-09-28 |
2006-06-13 |
3-Dimensional Pharmaceuticals, Inc. |
Quinazolinones
|
US6890930B1
(en)
*
|
1999-09-28 |
2005-05-10 |
3-Dimensional Pharmaceuticals, Inc. |
Quinazolinones
|
US6545004B1
(en)
*
|
1999-10-27 |
2003-04-08 |
Cytokinetics, Inc. |
Methods and compositions utilizing quinazolinones
|
US6562830B1
(en)
*
|
1999-11-09 |
2003-05-13 |
Cell Pathways, Inc. |
Method of treating a patient having precancerous lesions with phenyl quinazolinone derivatives
|
US6664390B2
(en)
|
2000-02-02 |
2003-12-16 |
Warner-Lambert Company Llc |
Method for the simplified production of (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-nitro-quinazoline-4-yl]-amine or (3-chloro-4-fluorophenyl)-[7-(3-morpholin-4-yl-propoxy)-6-amino-quinazoline-4-yl]-amine
|
US6697213B2
(en)
*
|
2000-03-31 |
2004-02-24 |
Seagate Technology Llc |
Cover including multiple cover plates with damped layers
|
CA2406947A1
(en)
|
2000-04-19 |
2001-10-25 |
Johns Hopkins University |
Methods for prevention and treatment of gastrointestinal disorders
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
ES2527754T3
(es)
*
|
2000-04-25 |
2015-01-29 |
Icos Corporation |
Inhibidores de la isoforma delta de la fosfatidilinositol 3-quinasa humana
|
EP1308436B1
(en)
*
|
2000-08-11 |
2008-10-15 |
Japan Tobacco Inc. |
Calcium receptor antagonists
|
EP1188438A1
(en)
|
2000-09-15 |
2002-03-20 |
Warner-Lambert Company |
Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
|
WO2002024667A1
(en)
*
|
2000-09-20 |
2002-03-28 |
Merck Patent Gmbh |
4-amino-quinazolines
|
WO2002024695A2
(en)
*
|
2000-09-22 |
2002-03-28 |
Ortho Mcneil Pharmaceutical, Inc. |
Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
|
EP1331950B1
(en)
*
|
2000-10-13 |
2009-10-14 |
The Johns Hopkins University |
Ex vivo methods and compositions for nucleic acid delivery
|
CA2426730A1
(en)
*
|
2000-10-25 |
2002-05-16 |
Smithkline Beecham Corporation |
Calcilytic compounds
|
US6964967B2
(en)
|
2000-12-11 |
2005-11-15 |
Amgen, Inc. |
Substituted pyrido[2,3-d]pyrimidines and methods for their use
|
US6900220B2
(en)
*
|
2001-01-02 |
2005-05-31 |
Syntex (U.S.A.) Llc |
Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
|
HUP0303249A3
(en)
|
2001-02-22 |
2007-03-28 |
Sankyo Co |
Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
|
EP1396488A1
(en)
|
2001-05-23 |
2004-03-10 |
Mitsubishi Pharma Corporation |
Fused heterocyclic compound and medicinal use thereof
|
WO2002096905A1
(en)
*
|
2001-06-01 |
2002-12-05 |
Vertex Pharmaceuticals Incorporated |
Thiazole compounds useful as inhibitors of protein kinases
|
US7220777B2
(en)
*
|
2001-10-15 |
2007-05-22 |
Smithkline Beecham P.L.C. |
Lactam derivatives as antagonists for human 11cby receptors
|
AU2002363429B2
(en)
|
2001-11-07 |
2008-05-08 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
US20040110777A1
(en)
*
|
2001-12-03 |
2004-06-10 |
Annis Gary David |
Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests
|
JP2005526714A
(ja)
*
|
2002-01-17 |
2005-09-08 |
ニューロジェン・コーポレーション |
カプサイシンのモジュレーターとしての置換キナゾリン−4−イルアミン類縁体
|
JP2005529076A
(ja)
*
|
2002-02-15 |
2005-09-29 |
サイトキネティクス・インコーポレーテッド |
キナゾリノンの合成
|
US6559293B1
(en)
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
JP2005524695A
(ja)
|
2002-04-26 |
2005-08-18 |
アルタナ ファルマ アクチエンゲゼルシャフト |
呼吸機能不全を治療するためのグアニル酸シクラーゼ活性化剤の新規の使用
|
CN1665808A
(zh)
|
2002-05-06 |
2005-09-07 |
沃泰克斯药物股份有限公司 |
噻二唑或噁二唑及其作为jak蛋白激酶抑制剂的用途
|
WO2003097053A1
(en)
*
|
2002-05-09 |
2003-11-27 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
ATE478867T1
(de)
*
|
2002-05-23 |
2010-09-15 |
Novartis Vaccines & Diagnostic |
Substituierte quinazolinone verbindungen
|
AU2003299517A1
(en)
*
|
2002-05-23 |
2004-05-25 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
AU2003265242A1
(en)
*
|
2002-05-23 |
2003-12-22 |
Cytokinetics, Inc. |
Compounds, compositions, and methods
|
JP2006501201A
(ja)
*
|
2002-07-23 |
2006-01-12 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
US20040048853A1
(en)
|
2002-08-21 |
2004-03-11 |
Gustave Bergnes |
Compounds, compositions, and methods
|
US20040242572A1
(en)
|
2002-08-24 |
2004-12-02 |
Boehringer Ingelheim International Gmbh |
New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
|
JP2006501306A
(ja)
|
2002-09-30 |
2006-01-12 |
サイトキネティクス・インコーポレーテッド |
化合物、組成物および方法
|
KR20110050745A
(ko)
|
2002-10-03 |
2011-05-16 |
탈자진 인코포레이티드 |
혈관항상성 유지제 및 그의 사용 방법
|
GB0223730D0
(en)
*
|
2002-10-11 |
2002-11-20 |
Novartis Ag |
Organic compounds
|
WO2004037176A2
(en)
*
|
2002-10-21 |
2004-05-06 |
Bristol-Myers Squibb Company |
Quinazolinones and derivatives thereof as factor xa inhibitors
|
US20060052345A1
(en)
*
|
2002-11-04 |
2006-03-09 |
Nps Pharmaceuticals, Inc. |
Quinazolinone compounds as calcilytics
|
FR2846657B1
(fr)
*
|
2002-11-05 |
2004-12-24 |
Servier Lab |
Nouveaux composes pyridopyrimidinone, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
AU2003300791A1
(en)
*
|
2002-12-13 |
2004-07-09 |
Neurogen Corporation |
Combination therapy for the treatment of pain
|
GB0230015D0
(en)
*
|
2002-12-23 |
2003-01-29 |
Novartis Ag |
Organic compounds
|
EP1611125A1
(en)
|
2003-02-07 |
2006-01-04 |
Vertex Pharmaceuticals Incorporated |
Heteroaryl substituted pyrolls useful as inhibitors of protein kinases
|
TW200508224A
(en)
|
2003-02-12 |
2005-03-01 |
Bristol Myers Squibb Co |
Cyclic derivatives as modulators of chemokine receptor activity
|
CL2004000409A1
(es)
|
2003-03-03 |
2005-01-07 |
Vertex Pharma |
Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
|
ATE398125T1
(de)
|
2003-03-12 |
2008-07-15 |
Millennium Pharm Inc |
Chinazolin-derivate als tgf-beta-inhibitoren
|
US7488757B2
(en)
*
|
2003-03-24 |
2009-02-10 |
Becton, Dickinson And Company |
Invisible antimicrobial glove and hand antiseptic
|
US7550590B2
(en)
|
2003-03-25 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
JP4926473B2
(ja)
|
2003-03-27 |
2012-05-09 |
協和発酵キリン株式会社 |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
ES2423800T3
(es)
*
|
2003-03-28 |
2013-09-24 |
Novartis Vaccines And Diagnostics, Inc. |
Uso de compuestos orgánicos para la inmunopotenciación
|
AU2004230903A1
(en)
*
|
2003-04-07 |
2004-10-28 |
Nps Pharmaceuticals, Inc. |
Pyrimidinone compounds as calcilytics
|
ES2359451T3
(es)
*
|
2003-04-07 |
2011-05-23 |
Nps Pharmaceuticals, Inc. |
Compuestos de pirimidona en calidad de calcilíticos.
|
US20070161792A1
(en)
*
|
2003-04-07 |
2007-07-12 |
Nps Pharmacueticals, Inc |
Methods for preparing 2,3,5,6-substituted 3h-pyrimidin-4-ones
|
GB0309009D0
(en)
*
|
2003-04-22 |
2003-05-28 |
Astrazeneca Ab |
Quinazoline derivatives
|
MXPA05012302A
(es)
*
|
2003-05-22 |
2006-01-30 |
Altana Pharma Ag |
Composicion que comprende un inhibidor de pde4 y un inhibidor de pde5.
|
KR20060018217A
(ko)
*
|
2003-05-23 |
2006-02-28 |
카이론 코포레이션 |
Mc4-r 작용제로서 구아니디노-치환된 퀴나졸리논 화합물
|
CA2527017A1
(en)
|
2003-05-27 |
2004-12-09 |
Pfizer Products Inc. |
Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
|
JP5044214B2
(ja)
|
2003-06-06 |
2012-10-10 |
アレクシス・アクチボラゲット |
皮膚状態または癌の処置のためのscce阻害剤としての縮合複素環化合物の使用
|
WO2005051974A2
(en)
*
|
2003-06-09 |
2005-06-09 |
The Regents Of The University Of California |
Novel molecules for regulating cell death
|
CA2529007C
(en)
|
2003-06-16 |
2012-03-27 |
Altana Pharma Ag |
Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
|
WO2005002585A1
(en)
*
|
2003-07-02 |
2005-01-13 |
Warner-Lambert Company Llc |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
CN1845924A
(zh)
*
|
2003-07-02 |
2006-10-11 |
弗·哈夫曼-拉罗切有限公司 |
芳基胺取代的喹唑啉酮化合物
|
AU2004253967B2
(en)
*
|
2003-07-03 |
2010-02-18 |
Cytovia, Inc. |
4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
|
US20050043239A1
(en)
|
2003-08-14 |
2005-02-24 |
Jason Douangpanya |
Methods of inhibiting immune responses stimulated by an endogenous factor
|
JP2007512230A
(ja)
*
|
2003-08-20 |
2007-05-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼ阻害剤として有用な(4−アミノ−1,2,5−オキサジアゾール−4−イル)−ヘテロ芳香族化合物
|
WO2005020897A2
(en)
*
|
2003-08-22 |
2005-03-10 |
Dendreon Corporation |
Compositions and methods for the treatment of disease associated with trp-p8 expression
|
US20050059862A1
(en)
*
|
2003-09-12 |
2005-03-17 |
Scimed Life Systems, Inc. |
Cannula with integrated imaging and optical capability
|
JP2007505873A
(ja)
*
|
2003-09-16 |
2007-03-15 |
アストラゼネカ アクチボラグ |
チロシンキナーゼ阻害剤としてのキナゾリン誘導体
|
US20050059851A1
(en)
*
|
2003-09-17 |
2005-03-17 |
Vincent Ardizzone |
Flexible magnetic pad with multi-directional constantly alternating polarity zones
|
TW200524892A
(en)
|
2003-09-24 |
2005-08-01 |
Glaxo Group Ltd |
Calcilytic compounds
|
GB0325175D0
(en)
*
|
2003-10-28 |
2003-12-03 |
Novartis Ag |
Organic compounds
|
GB0326459D0
(en)
|
2003-11-13 |
2003-12-17 |
Astrazeneca Ab |
Quinazoline derivatives
|
KR20060105785A
(ko)
|
2003-11-19 |
2006-10-11 |
카이론 코포레이션 |
감소된 생체축적을 갖는 퀴나졸리논 화합물
|
JP2007512364A
(ja)
*
|
2003-11-21 |
2007-05-17 |
アレイ バイオファーマ、インコーポレイテッド |
Aktプロテインキナーゼインヒビター
|
EP2305221B1
(en)
|
2003-12-01 |
2015-05-20 |
Kudos Pharmaceuticals Limited |
DNA damage repair inhibitors for treatment of cancer
|
US20050136085A1
(en)
*
|
2003-12-19 |
2005-06-23 |
David Bellamy |
Panthenol and natural organic extracts for reducing skin irritation
|
CA2549641A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Merck & Co., Inc. |
Mitotic kinesin inhibitors
|
US20070149553A1
(en)
*
|
2003-12-19 |
2007-06-28 |
Arrington Kenneth L |
Mitotic kinesin inhibitors
|
US20050239809A1
(en)
|
2004-01-08 |
2005-10-27 |
Watts Stephanie W |
Methods for treating and preventing hypertension and hypertension-related disorders
|
EP1711504A2
(en)
|
2004-01-21 |
2006-10-18 |
Molecular Probes Inc. |
Derivatives of cephalosporin and clavulanic acid for detecting beta-lactamase in a sample
|
BRPI0507629A
(pt)
|
2004-02-13 |
2007-07-03 |
Banyu Pharma Co Ltd |
composto, antagonista do receptor e agonista inverso do receptor da histamina h3, agente profilático ou terapêutico para uma doença metabólica, uma doença circulatória ou uma doença do sistema nervoso, ou um seu sal farmaceuticamente aceitável
|
EP1740183B8
(en)
|
2004-03-05 |
2009-11-25 |
Nycomed GmbH |
Novel use for pde5 inhibitors
|
WO2005100342A1
(en)
|
2004-03-26 |
2005-10-27 |
Vertex Pharmaceuticals, Incorporated |
Pyridine inhibitors of erk2 and uses thereof
|
RU2445095C2
(ru)
|
2004-04-22 |
2012-03-20 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Новые фармацевтические композиции для лечения сексуальных расстройств
|
WO2005108376A1
(en)
*
|
2004-05-06 |
2005-11-17 |
Smithkline Beecham Corporation |
Calcilytic compounds
|
EP1750714A1
(en)
*
|
2004-05-13 |
2007-02-14 |
Vanderbilt University |
Phosphoinositide 3-kinase delta selective inhibitors for inhibiting angiogenesis
|
EP1755609A1
(en)
*
|
2004-05-25 |
2007-02-28 |
Icos Corporation |
Methods for treating and/or preventing aberrant proliferation of hematopoietic cells
|
EP1756088A1
(en)
|
2004-06-04 |
2007-02-28 |
AstraZeneca AB |
Quinazoline derivatives as erbb receptor tyrosine kinases
|
US7429604B2
(en)
*
|
2004-06-15 |
2008-09-30 |
Bristol Myers Squibb Company |
Six-membered heterocycles useful as serine protease inhibitors
|
US7939538B2
(en)
*
|
2004-06-28 |
2011-05-10 |
Amgen Inc. |
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
|
TW200605430A
(en)
*
|
2004-07-20 |
2006-02-01 |
Avision Inc |
Electrical magnetic interference inspecting system
|
US7203079B2
(en)
*
|
2004-07-23 |
2007-04-10 |
System General Corp. |
Switching controller having frequency hopping for power supplies
|
US20060025420A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Boehringer Ingelheimn International GmbH |
Pharmaceutical compositions for the treatment of female sexual disorders
|
US7718658B2
(en)
*
|
2004-09-02 |
2010-05-18 |
Vertex Pharmaceuticals Incorporated |
Quinazolines useful as modulators of ion channels
|
WO2006034196A1
(en)
*
|
2004-09-17 |
2006-03-30 |
Lifelike Biomatic Inc. |
Compositions for enhancing memory and methods therefor
|
US8011027B2
(en)
*
|
2004-11-17 |
2011-09-06 |
Interspiro, Inc. |
Protective seal mechanism
|
JP2006151028A
(ja)
*
|
2004-11-25 |
2006-06-15 |
Sumitomo Rubber Ind Ltd |
タイヤとリムとの組立体およびこれに用いるサポートリング
|
US7466645B2
(en)
*
|
2004-12-21 |
2008-12-16 |
Panasonic Corporation |
OFDM signal receiving apparatus
|
US20070032506A1
(en)
*
|
2005-07-02 |
2007-02-08 |
Peter Giannousis |
Crystalline forms of (2r-trans)-6-chloro-5[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride
|
RU2008130111A
(ru)
*
|
2005-12-22 |
2010-01-27 |
Алькон Рисерч, Лтд. (Us) |
(индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний
|
TWI338846B
(en)
*
|
2006-12-22 |
2011-03-11 |
Univ Nat Pingtung Sci & Tech |
A method for grid-based data clustering
|
EP1964548A1
(en)
|
2007-03-02 |
2008-09-03 |
Novartis AG |
Pharmaceutical compositions comprising a calcilytic agent
|
AU2010204106B2
(en)
*
|
2009-01-08 |
2014-05-08 |
Resverlogix Corp. |
Compounds for the prevention and treatment of cardiovascular disease
|